Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for PVP-I  COVID-19 treatment studies for Povidone-Iod..  C19 studies: Povidone-Iod..  Povidone-Iod..   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Viral clearance 86% Improvement Relative Risk c19early.org/p Mohamed et al. Povidone-Iodine for COVID-19 RCT EARLY Is early treatment with povidone-iodine beneficial for COVID-19? RCT 10 patients in Malaysia Improved viral clearance with povidone-iodine (not stat. sig., p=0.17) Mohamed et al., medRxiv, doi:10.1101/2020.09.07.20180448 Favors povidone-iodine Favors control
Early viral clearance among COVID-19 patients when gargling with povidone-iodine and essential oils: a pilot clinical trial
Mohamed et al., medRxiv, doi:10.1101/2020.09.07.20180448 (Preprint)
Mohamed et al., Early viral clearance among COVID-19 patients when gargling with povidone-iodine and essential oils: a pilot.., medRxiv, doi:10.1101/2020.09.07.20180448 (Preprint)
Sep 2020   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Tiny RCT with 5 PVP-I patients, gargling 30 seconds, 3x per day, and 5 control patients (essential oils and tap water were also tested), showing improved viral clearance with PVP-I.
risk of no viral clearance, 85.7% lower, RR 0.14, p = 0.17, treatment 0 of 5 (0.0%), control 3 of 5 (60.0%), NNT 1.7, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), day 12.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Mohamed et al., 9 Sep 2020, Randomized Controlled Trial, Malaysia, preprint, 16 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperPovidone-Iod..All
Abstract: medRxiv preprint doi: https://doi.org/10.1101/2020.09.07.20180448; this version posted September 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. EARLY VIRAL CLEARANCE AMONG COVID-19 PATIENTS WHEN GARGLING WITH POVIDONE-IODINE AND ESSENTIAL OILS – A CLINICAL TRIAL *Nurul Azmawati Mohamed1, Nizam Baharom1, Wan Shahida Wan Sulaiman1, Zetti Zainol Rashid2, Wong Kon Ken2, Umi Kalsom Ali2, Siti Norlia Othman2, Muttaqillah Najihan Samat2, Najma Kori3, Petrick Periyasamy3, Nor Azizan Zakaria3, Agni Nhirmal Kumar Sugurmar3, Nur Ezzaty Mohammad Kazmin4, Cheong Xiong Khee3, Siti Mariyam Saniman3, Ilina Isahak1 1 Department of Basic Medical Sciences 2, Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia, Pandan Indah, 55100 Kuala Lumpur, Malaysia 2 Department of Microbiology and Immunology, Hospital Canselor Tuanku Mukhriz, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Kuala Lumpur, Malaysia 3 Department of Medicine, Hospital Canselor Tuanku Mukhriz, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Kuala Lumpur, Malaysia 4 Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia, Pandan Indah, 55100, Kuala Lumpur, Malaysia Corresponding author: Nurul Azmawati Mohamed Department of Basic Medical Sciences 2 Faculty of Medicine & Health Sciences Universiti Sains Islam Malaysia Jalan Pandan Utama, Pandan Indah 55100 Kuala Lumpur, Malaysia Tel: 603 4289 2400 Email: drnurul@usim.edu.my Declaration: not applicable Funding: none Conflict of Interest: The authors have declared that no conflict of interest exist. Availability of data: upon request NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.09.07.20180448; this version posted September 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Background: Gargling had been reported to have significant roles in the prevention and treatment of respiratory tract infections. The purpose of this study was to assess the ability of regular gargling to eliminate SARS-CoV-2 in the oropharynx and nasopharynx. Methodology: This pilot, open labeled, randomized, parallel study compared the effect of 30 seconds, 3 times/day gargling using 1% povidone-iodine (PVP-I), essential oils and tap water on SARS-CoV-2 viral clearance among COVID-19 patients in a tertiary hospital in Kuala Lumpur. Progress was monitored by day 4,6 and 12 PCR (Ct value), gargling and symptoms diary as well as clinical observations. Results: Five confirmed Stage 1 COVID-19 patients were recruited for each arm. The age range was from 22 to 56 years old. The majority were males. Two respondents had co-morbidities, which were asthma and obesity. Viral clearance was achieved at day 6 in 100%, 80%, 20% and 0% for 1% PVP-I, essential oils, tap water and control group respectively. Analysis of 1% PVP-I group versus control group showed significant p-value for comparison of PCR results on Day 4, Day 6 and Day 12. Conclusions: This preliminary study showed that gargling with 1% PVP-I..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit